Professor Gary Maartens
Gary Maartens is Emeritus Professor in the Division of Clinical Pharmacology. His research interests include therapeutic aspects of HIV-associated tuberculosis (TB), drug-resistant TB, antiretroviral (ARV) therapy adherence, and the pharmacokinetics of ARV and anti-TB drugs.
He has published over 300 peer reviewed articles, including invited seminars on both tuberculosis and HIV for the Lancet. He has been involved in international guideline development for the management of drug-resistant TB and HIV-TB co-treatment for the World Health Organization, and prevention and treatment of opportunistic infections in HIV for the joint guidelines from CDC, NIH, and IDSA. He served on the Tuberculosis Transformative Science Group of the AIDS Clinical Trials Group, NIH for ten years from 2011-2021.
Gary was the founding president of the College of Clinical Pharmacologists in 2008. In 2015 he was awarded a gold medal for outstanding contributions to medical research by the Medical Research Council of South Africa.